Marie Chevalier

Research

My PhD focuses on understanding the tumour microenvironment in cutaneous T-cell lymphomas. To achieve this, I integrate multiple state-of-the-art methodologies, including imaging mass cytometry, spatial transcriptomics, and single-cell RNA sequencing. By investigating distinct disease characteristics—such as patient survival, spontaneous lesion regression, and different stages of disease progression—we aim to identify biomarkers that can predict disease outcome. Ultimately, this work seeks to enable more precise prognostication and support the development of personalized treatment strategies for patients with cutaneous T-cell lymphomas.

CV

After completing my medical degree in January 2024, I began my PhD, which is a collaboration between the departments of Dermatology and Pathology. Within the department of Dermatology, I am part of the Cutaneous Lymphoma Group, led by Maarten Vermeer. At the Department of Pathology, I work within both the Cancer Immunogenomics Group, led by Noel de Miranda, and the Cutaneous Lymphoma Pathology Group, led by Anne-Roos Schrader.